- Published at
- by gurufocus.com
mixed
mixed
STAAR Surgical Announces Leadership Transition
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICLâ„¢) for vision correction
News for Mallinckrodt plc (MNK)
- Published at
- by gurufocus.com
positivepositiveBracebridge Capital, LLC Acquires New Stake in Mallinckrodt PLC
On November 19, 2024, Bracebridge Capital, LLC (Trades, Portfolio) executed a noteworthy transaction by acquiring 355,449 shares of Mallinckrodt PLC. This acqui- Published at
- by investing.com
neutralneutralMallinckrodt Presents Data on TERLIVAZ ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at Kidney Week 2024 By Investing.com
Mallinckrodt Presents Data on TERLIVAZ ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at Kidney Week 2024- Published at
- by gurufocus.com
positivepositiveHudson Bay Capital Management LP Acquires New Stake in Mallinckrodt PLC
Overview of Hudson Bay's Recent Transaction On May 31, 2024, Hudson Bay Capital Management LP (Trades, Portfolio) made a significant move in the pharmaceutical- Published at
- by investing.com
mixedmixedStructure Therapeutics Appoints Angus C. Russell to Board of Directors By Investing.com
Structure Therapeutics Appoints Angus C. Russell to Board of Directors- Published at
- by globenewswire.com
mixedmixedGlobal Substance Use Disorder Treatment Market Poised for Robust Growth, Projected to Reach USD 67.6 Billion by 2034 | Future Market Insights, Inc.
The United States is anticipated to experience a 1.4% CAGR growth in the substance use disorder treatment sector during the assessment period. Key to this...- Published at
- by investing.com
mixedmixedAgilent to buy contract drug manufacturer Biovectra for $925 million By Reuters
Agilent to buy contract drug manufacturer Biovectra for $925 million- Published at
- by investing.com
positivepositiveGoldenTree asset management purchases Mallinckrodt shares worth over $720k By Investing.com
GoldenTree asset management purchases Mallinckrodt shares worth over $720k- Published at
- by investing.com
neutralneutralMallinckrodt Presents Data on TERLIVAZ ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at the 2024 Digestive Disease Week ® (DDW) By Investing.com
Mallinckrodt Presents Data on TERLIVAZ ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at the 2024 Digestive Disease Week ® (DDW)- Published at
- by marketscreener.com
mixedmixed- Published at
- by marketscreener.com
neutralneutralBuxton Helmsley Issues Letter to U.S. Senators Warren and Whitehouse Related to Apparent EchoStar Accounting and Securities Fraud, Including Failure to Correct $15B Equity Value Overstatement
The Buxton Helmsley Group, Inc. , the New York City-based investment fund manager with financial interests in EchoStar Corporation , today issued an open letter to U.S. Senators Elizabeth Warren...- Published at
- by marketscreener.com
mixedmixedAlkermes Announces Appointment of Nancy S. Lurker to Board of Directors
DUBLIN, March 7, 2024 /PRNewswire/ -- Alkermes plc today announced the appointment of a new independent director, Nancy S. Lurker, to the company's Board of Directors . Ms. Lurker is a seasoned...- Published at
- by financialpost.com
mixedmixedNorthStar Medical Technologies, LLC Announces Appointment of Barbara Bodem and David Keeling to Board of Managers
BELOIT, Wis. — NorthStar Medical Technologies, LLC, parent company of NorthStar Medical Radioisotopes, LLC, a global innovator in development, production and…- Published at
- by benzinga.com
mixedmixedDow Drops Over 100 Points; Crude Oil Rises - Chemours (NYSE:CC), Bellerophon Therapeutics (NASDAQ:BLPH)
U.S. stocks traded mixed toward the end of trading, with Dow Jones dropping over 100 points on Monday. The Dow traded down 0.33% to 33,651.23 while the NASDAQ rose 0.30% to 13,279.88. The S&P 500, also rose, gaining, 0.11% to 4,286.88.- Published at
- by prnewswire.com
positivepositive- Published at
- by globenewswire.com
mixedmixedAttention Deficit Hyperactivity Disorder Market to Register a Steady CAGR of 4.40% Between 2023 – 2031 | Growth Plus Reports
Newark, New Castle, USA, April 03, 2023 (GLOBE NEWSWIRE) -- The global attention deficit hyperactivity disorder market, estimated at US$ 13.60 billion in...- Published at
- by etfdailynews.com
mixedmixedAnalyzing Kiora Pharmaceuticals (NASDAQ:KPRX) & Mallinckrodt (OTCMKTS:MNKKQ)
Read Analyzing Kiora Pharmaceuticals (NASDAQ:KPRX) & Mallinckrodt (OTCMKTS:MNKKQ) at ETF Daily News- Published at
- by financialpost.com
mixedmixed- Published at
- by prnewswire.com
mixedmixedChronic Disease Management: Therapeutics, Device Technologies and Global Markets, 2020-2021 & 2026
/PRNewswire/ -- TheWSTVTRSVVTRS.MXVTRSVIA.DESUNPHARMA-BL.NSDNPUF4506.TZGNXYPSN.SWPFED.BAPFECL.SNPFE.SNPFE.MXPFE.DEPFEOTSKYOTSKFOPHLYOPHLFOMCLNVSN.MXNVSEFNVSD.BANVSNURONOVN.SWNMRDN1VS34.SAMNKKQMNKJNJIPSEYIPNN.MXIPN.PAGSK.LGSKGS7.DEGLAXFGIS.DEGILDD.BAGILD.MXGILDDJNJ3.BADJNJ2.BABSX.MXBSX-PABSXBHCN.MXBHC.TOBHCB1SX34.SAAMGN.MXAMGN.BAAMGNAMG.DEALPMYALPMFABBV34.SAABBV.MXABBV.BAABBV4AB.DE4578.T4528.T4503N.MX290660.KQ0QLQ.L0M3O.L0K9E.L0HOY.L- Published at
- by scoop.co.nz
positivepositiveHemostats Market Projected To Reach $4,829.8 Million By 2031
Hemostats Market Projected to Reach $4,829.8 Million by 2031 – Top Key Players: Anika Therapeutics Inc. , C.R. Bard, B. Braun Melsungen An overview of the market segment, size, share, sectional analysis, and revenue forecast, as well as a complete ...